RET and cancer: Here, we reported there were approximately 3.0% of RET alterations among 10,967 TCGA cancers with somatic mutations in the other domains (172 cases) being the most frequent variant, followed by mutations in the PKinase_Tyr domain (63 cases), RET fusions (42 cases) and other alterations, respectively.